POLITICO | A ‘Plan A’ for Men
ORIGINALLY POSTED ON POLITICO
APRIL 2024
For decades, the responsibility for birth control has disproportionately fallen on women. Now, several companies are working on male birth control.
Male contraception is in demand. Between 2014 and 2021, the rate of vasectomies among men 18-64 grew 26 percent, according to one study. Vasectomies jumped again after the Supreme Court overturned the constitutional right to an abortion in 2022.
In the U.K., an oral contraceptive has entered safety trials. But two companies, NEXT Life Sciences and Contraline, are each exploring the possibility of using hydrogel to block sperm. Both have clinical trials underway.
Ruth sat down with NEXT Life Sciences CEO Luke R. Fox to talk about his company’s male contraceptive, Plan A, and the future of male birth control.